The Laryngoscope · 2026
Feasibility of Awake In-Office Transnasal Double Balloon Dilation of the Pharyngoesophageal Segment.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Clark Christine M, Doruk Can, Mocchetti Valentina, Rameau Anaïs
Аннотация
OBJECTIVES: To review experience with and describe the feasibility of unsedated in-office transnasal double balloon dilations of the pharyngoesophageal segment (PES).
METHODS: Adults who underwent office-based transnasal double balloon dilations of the PES at a single academic institution over a 3-year period were retrospectively studied. Clinicodemographic data, prior PES dilation history, procedural indications, pre-procedure anxiolytic usage, procedural data including the number of office-based double balloon dilation procedures performed and dilation diameter, complications, and subjective outcomes at 2 weeks post-dilation were recorded.
RESULTS: Nineteen office-based double balloon dilations to 24 mm (12 + 12-mm balloons) were performed in seven patients (mean age: 65.3 years, 57.1% female). Indications for dilation were varied. Two (28.6%) patients had a history of oropharyngeal cancer treated with radiation therapy. No patients were post-laryngectomy. The majority (85.7%) of patients underwent at least one prior in-office transnasal single balloon dilation. Two (28.6%) patients required a pre-procedure anxiolytic. One complication occurred involving post-procedure epistaxis that resolved with topical oxymetazoline application. No esophageal lacerations or perforations were encountered. No procedures required early termination due to poor patient tolerance. The majority (71.4%) of patients reported subjective improvement in dysphagia symptoms at 2-week follow-up.
CONCLUSION: Double balloon dilation of the PES is feasible in unsedated patients in the office setting.
METHODS: Adults who underwent office-based transnasal double balloon dilations of the PES at a single academic institution over a 3-year period were retrospectively studied. Clinicodemographic data, prior PES dilation history, procedural indications, pre-procedure anxiolytic usage, procedural data including the number of office-based double balloon dilation procedures performed and dilation diameter, complications, and subjective outcomes at 2 weeks post-dilation were recorded.
RESULTS: Nineteen office-based double balloon dilations to 24 mm (12 + 12-mm balloons) were performed in seven patients (mean age: 65.3 years, 57.1% female). Indications for dilation were varied. Two (28.6%) patients had a history of oropharyngeal cancer treated with radiation therapy. No patients were post-laryngectomy. The majority (85.7%) of patients underwent at least one prior in-office transnasal single balloon dilation. Two (28.6%) patients required a pre-procedure anxiolytic. One complication occurred involving post-procedure epistaxis that resolved with topical oxymetazoline application. No esophageal lacerations or perforations were encountered. No procedures required early termination due to poor patient tolerance. The majority (71.4%) of patients reported subjective improvement in dysphagia symptoms at 2-week follow-up.
CONCLUSION: Double balloon dilation of the PES is feasible in unsedated patients in the office setting.